30 April 2026, China: Syngenta Group announced its financial results for the first quarter of 2026, reporting growth across all four business units along with continued margin expansion.

The results reflect the Group's ongoing transformation toward a higher-margin, innovation-led portfolio, with strong contributions from next-generation technologies, biologicals, and AI-enabled agronomy solutions.

First quarter 2026 sales grew by 2% to $6.4 billion (-4% at CER). The innovation portfolio delivered strong commercial results across all strategic geographies, supported by new product introductions, despite a market environment shaped by geopolitical uncertainty and trade disruptions.

EBITDA for the first quarter rose to $1.4 billion, up 5% (1% at CER) year-on-year. EBITDA margin expanded by around 0.6 percentage points to 21.9%, compared to 21.4% in Q1 2025, driven by a focus on higher-margin businesses, disciplined cost management, and operational efficiency improvements.

The Group's AI programs continued to generate measurable business impact, with initiatives established in 2025 now scaling across product development, precision agronomy, and commercial operations.

Q1 2026 Financial Overview

Syngenta Crop Protection reported Q1 sales of $3.5 billion, up 3% (-3% CER), supported by a positive business environment in China and Europe.

Sales in Europe rose by 18% (5% CER), driven by favourable crop conditions and strong biologicals performance, including approvals for ORONDIS® in Austria, Germany, and the Netherlands for downy mildew control in high-value crops.

Asia, Middle East & Africa (excluding China) grew by 3%, while China recorded 20% growth with strong demand for biologicals. Growth in AMEA was supported by TYMIRIUM® and PLINAZOLIN® technologies, while China saw continued demand for ADEPIDYN® and TYMIRIUM® technologies.

In contrast, Brazil and Latin America reported declines of 3% and 16% respectively, impacted by adverse weather, pricing pressures in Mexico, and high channel inventory in Argentina. TYMIRIUM® technology was launched in Brazil and Latin America, while VIRESTINA™ technology received its first global registration in Argentina. INCIPIO® was approved in Mexico for red mite control in vegetables.

North America sales declined by 12% due to a planned shift in channel stocking timing, although early demand was observed for PLINAZOLIN® and TYMIRIUM®-based products.

Syngenta Crop Protection achieved nearly 350 product approvals in Q1 2026. Groundbreaking ceremonies were held for new R&D sites in Shanghai (China) and at Jealott's Hill (UK), including the BioSTaR facility.

Seeds sales reached $1.5 billion in Q1 2026, up 7% year-on-year (1% CER).

Field crop sales showed broad-based growth, led by strong Southern Hemisphere campaigns. Latin America recorded a 60% increase, with Brazil up 26%. Asia, Middle East & Africa grew by 11%, Europe by 9%, and China by 8%. North America declined by 3% due to restructuring activities.

Vegetable seeds sales increased by 4%, while flowers grew by 5%.

The company highlighted ongoing demand generation efforts in LATAM, Brazil, and AMEA. Europe launched X-Terra® hybrid wheat in France, with future launches planned in the UK (2027) and Germany (2029). China introduced Viptera Pro corn, while North America achieved near sell-out levels in corn and introduced a next-generation soybean trait stack combining Enlist E3® with the FG72 event.